These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9091683)
1. Prenatal magnesium sulfate exposure and risk of cerebral palsy. Allred EN; Dammann O; Kuban KK; Leviton A; Pagano M; Stewart JE; VanMarter LJ JAMA; 1997 Apr; 277(13):1033-4. PubMed ID: 9091683 [No Abstract] [Full Text] [Related]
2. Cerebral palsy in very low birth weight infants, pre-eclampsia and magnesium sulphate. Blair E; Palmer L; Stanley F Pediatrics; 1996 May; 97(5):780-2. PubMed ID: 8628635 [No Abstract] [Full Text] [Related]
3. Magnesium sulfate and risk of cerebral palsy in very low-birth-weight infants. Nelson KB JAMA; 1996 Dec; 276(22):1843-4. PubMed ID: 8946908 [No Abstract] [Full Text] [Related]
4. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Grether JK; Hoogstrate J; Walsh-Greene E; Nelson KB Am J Obstet Gynecol; 2000 Sep; 183(3):717-25. PubMed ID: 10992199 [TBL] [Abstract][Full Text] [Related]
5. Magnesium sulfate tocolysis and risk of neonatal death. Grether JK; Hoogstrate J; Selvin S; Nelson KB Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):1-6. PubMed ID: 9465794 [TBL] [Abstract][Full Text] [Related]
6. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. Schendel DE; Berg CJ; Yeargin-Allsopp M; Boyle CA; Decoufle P JAMA; 1996 Dec; 276(22):1805-10. PubMed ID: 8946900 [TBL] [Abstract][Full Text] [Related]
7. More on prenatal magnesium sulfate and risk of cerebral palsy. Nelson KB; Grether JK JAMA; 1997 Nov; 278(18):1493. PubMed ID: 9363965 [No Abstract] [Full Text] [Related]
8. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Nelson KB; Grether JK Pediatrics; 1995 Feb; 95(2):263-9. PubMed ID: 7838646 [TBL] [Abstract][Full Text] [Related]
9. Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1,750 grams. Boyle CA; Yeargin-Allsopp M; Schendel DE; Holmgreen P; Oakley GP Am J Epidemiol; 2000 Jul; 152(2):120-4. PubMed ID: 10909948 [TBL] [Abstract][Full Text] [Related]
10. An overview of the possible relationship between antenatal pharmacologic magnesium and cerebral palsy. Mittendorf R; Pryde PG J Perinat Med; 2000; 28(4):286-93. PubMed ID: 11031698 [TBL] [Abstract][Full Text] [Related]
11. Antenatal exposure to magnesium sulfate and neuroprotection in preterm infants. Costantine MM; Drever N Obstet Gynecol Clin North Am; 2011 Jun; 38(2):351-66, xi. PubMed ID: 21575805 [TBL] [Abstract][Full Text] [Related]
12. Short- and long-term outcomes in babies born after antenatal magnesium treatment. Mitani M; Matsuda Y; Shimada E; J Obstet Gynaecol Res; 2011 Nov; 37(11):1609-14. PubMed ID: 21733038 [TBL] [Abstract][Full Text] [Related]